COEPW
FinancialsZ Squared Inc - Warrants (31/10/2025)
Live · NASDAQ · May 9, Close
What's Moving COEPW Today?
No stock-specific AI insight has been generated for COEPW yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Trading
COEPW News
6 articles- Z Squared Provides Additional Information on Previously Disclosed Pro Rata DistributionYahoo Finance·Apr 27, 2026
- Z Squared Announces Completion of Business Combination with Coeptis Therapeutics and Listing on the Nasdaq Global MarketBenzinga·Apr 24, 2026
- Coeptis Announces Approval of Z Squared Inc.'s Nasdaq Listing ApplicationBenzinga·Apr 7, 2026
- Coeptis Anchors $800M Valuation in Dual-Sector Strategy; Vanderbilt Report Publishes CoverageYahoo Finance·Oct 1, 2025
- Coeptis (COEP) Extinguishes Convertible Note with YA II PN, LtdYahoo Finance·Jul 22, 2025
- Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in OncologyYahoo Finance·May 28, 2025
All 6 articles loaded
Price Data
Fundamentals
Trading
About Z Squared Inc - Warrants (31/10/2025)
Coeptis Therapeutics Holdings Inc is a biopharmaceutical and technology company. The biopharmaceutical division focuses on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Coeptis aims to advance treatment paradigms and improve patient outcomes through its research and development efforts. The technology division focuses on enhancing operational capabilities through technologies. This division features AI-powered marketing software and robotic process automation tools designed to optimize business processes and improve overall efficiency. It derives the majority of the revenue from the Technology segment.